EUVIMEDEUVIMED entdecken
Crossref

Epigenetic blockade of SOD2 boosts mitochondria ROS and cytoskeleton remodelling in cardiac fibrosis

Yun-Sen Zhang, Zhen-Yu Liu, Li-Chan Lin, Bin Tu, Sui Mao, Kai Song, Peng Liu, Jing-Jing Yang, Qi Chen, Jian-Yuan Zhao iD, Hui Tao iD

Cardiovascular Research · 24.02.2026 · 122 (1) · 66-80

DOI: 10.1093/cvr/cvaf257 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 18.11.2025. Verfasst von Yun-Sen Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, P.R. China. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Epigenesis, Genetic, Superoxide Dismutase, Mitochondria, Heart. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Anhui Provincial Natural Science Foundation, Excellent Youth Research Project in University of Anhui Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Mitochondria reactive oxygen species (ROS) play a critical role in the progression of cardiac fibrosis. Nonetheless, the role of mitochondria ROS in cardiac fibroblasts cytoskeletal remodelling and ferroptosis have not been explored. However, little is known about the epigenetic mechanisms through mitochondria ROS, cytoskeletal remodelling and ferroptosis in cardiac fibrosis (CF). Methods and results Cardiac fibroblast-specific methyl-CpG-binding protein 2 (MeCP2)-deficient mice and wild type mice were treated with Isoprenaline to induce replacement cardiac fibrosis. AAV9 carrying fibroblast-specific POSTN promoter-driven small hairpin RNA targeting superoxide dismutase 2(SOD2), and overexpression of SOD2 were administered to investigate their vital roles in cardiac fibrosis. Biochemical and histological analyses were performed to determine how MeCP2 transcriptional repression of SOD2 through mitochondria ROS, cytoskeletal remodelling and ferroptosis in cardiac fibrosis. The reconstitution of SOD2 in MeCP2-deficient cardiac fibroblasts and mouse hearts was performed to study its effect on mitochondria ROS, cytoskeletal remodelling, ferroptosis and fibrosis. Human heart tissue from patients with atrial fibrillation is used for translational validation. Downregulation of SOD2 in replacement cardiac fibrosis is associated with increased mitochondria ROS, decreased mitochondrial membrane potential (MMP), and enhanced cytoskeletal remodelling. Fibroblasts-specific SOD2 deficiency enhances mitochondrial ROS, decreases MMP, promotes cytoskeletal remodelling and fibroblasts ferroptosis, leading to cardiac fibrosis. Specifically, SOD2 downregulation is associated with elevated CpG 5mC levels. Mechanistically, methyl-CpG binding protein MeCP2 recognizes bond to SOD2 CpG 5mC and recruits H3K27me3, resulting in SOD2 transcriptional repression. MeCP2 knockdown rescues SOD2 inhibition and mitigates cytoskeletal remodelling, ferroptosis and fibrosis. In addition, human atrial fibrillation fibrotic atrial tissue exhibits signs of MeCP2 upregulation, SOD2 inhibition, elevated mitochondria ROS, and ferroptosis.

Conclusion

We demonstrated a novel epigenetic mechanism through which silencing of SOD2 boosts mitochondria ROS, cytoskeletal remodelling, ferroptosis and promotes cardiac fibrosis. Our findings provide new insights for the development of preventive measures for replacement cardiac fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesEpigenesis, GeneticSuperoxide DismutaseMitochondria, HeartCytoskeletonFibroblastsMyocardiumCardiomyopathiesAtrial FibrillationAnimalsFibrosisHumansMethyl-CpG-Binding Protein 2FerroptosisMice, KnockoutDisease Models, AnimalMaleMice, Inbred C57BLCells, CulturedSignal TransductionMembrane Potential, MitochondrialMice

Stichwörter der Autor:innen

Cardiac fibrosisCytoskeletal remodellingDNA methylationFibroblastMitochondrialROS

Substanzen

Reactive Oxygen SpeciesSuperoxide DismutaseMethyl-CpG-Binding Protein 2Mecp2 protein, mouse

Autor:innen und Institutionen

  • Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, P.R. China.
  • Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, P.R. China.
  • Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, P.R. China.
  • Institute for Developmental and Regenerative Cardiovascular Medicine, MOE-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, P…

ORCID-Profile: Jian-Yuan Zhao, Hui Tao

Förderung

  • National Natural Science Foundation of China
  • Anhui Provincial Natural Science Foundation
  • Excellent Youth Research Project in University of Anhui Province

Zitieren

APA

Zhang, Y. S., Liu, Z. Y., Lin, L. C., Tu, B., Mao, S., Song, K., Liu, P., Yang, J. J., Chen, Q., Zhao, J. Y., & Tao, H. (2026). Epigenetic blockade of SOD2 boosts mitochondria ROS and cytoskeleton remodelling in cardiac fibrosis. Cardiovascular Research, 122(1), 66-80. https://doi.org/10.1093/cvr/cvaf257

Vancouver

Zhang YS, Liu ZY, Lin LC, Tu B, Mao S, Song K, et al. Epigenetic blockade of SOD2 boosts mitochondria ROS and cytoskeleton remodelling in cardiac fibrosis. Cardiovascular Research. 2026;122(1):66-80. doi:10.1093/cvr/cvaf257

BibTeX
@article{Zhang2026,
  author = {Zhang, Yun-Sen and Liu, Zhen-Yu and Lin, Li-Chan and Tu, Bin and Mao, Sui and Song, Kai and Liu, Peng and Yang, Jing-Jing and Chen, Qi and Zhao, Jian-Yuan and Tao, Hui},
  title = {Epigenetic blockade of SOD2 boosts mitochondria ROS and cytoskeleton remodelling in cardiac fibrosis},
  journal = {Cardiovascular Research},
  year = {2026},
  volume = {122},
  number = {1},
  pages = {66--80},
  doi = {10.1093/cvr/cvaf257}
}
Kostenlos starten →